Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers
Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression
Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers
Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma
Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment
Ferroptosis-related signaling pathways in cancer drug resistance